These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23202262)

  • 1. Endogenous cost-effectiveness analysis and health care technology adoption.
    Jena AB; Philipson TJ
    J Health Econ; 2013 Jan; 32(1):172-80. PubMed ID: 23202262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health expenditure growth: looking beyond the average through decomposition of the full distribution.
    de Meijer C; O'Donnell O; Koopmanschap M; van Doorslaer E
    J Health Econ; 2013 Jan; 32(1):88-105. PubMed ID: 23202257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to think about future health care spending.
    Fuchs VR
    N Engl J Med; 2010 Mar; 362(11):965-7. PubMed ID: 20220179
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health, technology, and medical care spending.
    Lubitz J
    Health Aff (Millwood); 2005; 24 Suppl 2():W5R81-5. PubMed ID: 16186154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis for priority setting in health: penny-wise but pound-foolish.
    Baltussen R; Brouwer W; Niessen L
    Int J Technol Assess Health Care; 2005; 21(4):532-4. PubMed ID: 16262980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Federal initiatives to support rapid learning about new technologies.
    Tunis SR; Carino TV; Williams RD; Bach PB
    Health Aff (Millwood); 2007; 26(2):w140-9. PubMed ID: 17259196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the usefulness of budget impact analyses: a U.S. payer perspective.
    Watkins JB; Danielson D
    Value Health; 2014; 17(1):3-4. PubMed ID: 24438711
    [No Abstract]   [Full Text] [Related]  

  • 15. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 16. Making sense of medical technology.
    Cutler DM
    Health Aff (Millwood); 2006; 25(2):w48-50. PubMed ID: 16464902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-part payments for the reimbursement of investments in health technologies.
    Levaggi R; Moretto M; Pertile P
    Health Policy; 2014 Apr; 115(2-3):230-6. PubMed ID: 24268054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to evaluate whether a new technology in the operating room is cost-effective from society's viewpoint.
    Tan JM; Macario A
    Anesthesiol Clin; 2008 Dec; 26(4):745-64, viii. PubMed ID: 19041627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan.
    Hammad EA
    Value Health; 2016; 19(2):233-8. PubMed ID: 27021758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.